BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31879335)

  • 1. Amphotericin-induced pancytopenia in a patient with rhino-orbital mucormycosis.
    Gupta N; Soneja M
    Postgrad Med J; 2020 Sep; 96(1139):572. PubMed ID: 31879335
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
    Kaur K; Gurnani B
    Indian J Pharmacol; 2021; 53(5):417-419. PubMed ID: 34854414
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl.
    Tarani L; Costantino F; Notheis G; Wintergerst U; Venditti M; Di Biasi C; Friederici D; Pasquino AM
    Pediatr Diabetes; 2009 Jun; 10(4):289-93. PubMed ID: 18828793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
    Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T
    Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.
    Manesh A; John AO; Mathew B; Varghese L; Rupa V; Zachariah A; Varghese GM
    Mycoses; 2016 Dec; 59(12):765-772. PubMed ID: 27443253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhino-orbital-cerebral Mucormycosis.
    Niculae CM; Craciun L
    N Engl J Med; 2024 Mar; 390(12):e30. PubMed ID: 38502066
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhino-orbital-cerebral mucormycosis (ROCM): a comprehensive case review.
    DiBartolo MA; Kelley PS
    Aviat Space Environ Med; 2011 Sep; 82(9):913-6. PubMed ID: 21888278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
    Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Image of the week. Rhino-orbital mucormycosis].
    Quintano Ridero A; Rodríguez Borregán JC; Martín Fojaco J; Marco Moreno JM
    Med Clin (Barc); 2007 Nov; 129(18):720. PubMed ID: 18203338
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B.
    Saedi B; Sadeghi M; Seilani P
    J Laryngol Otol; 2011 Aug; 125(8):807-10. PubMed ID: 21729440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    Guimarães JA; Moura FC
    Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole.
    Gelston CD; Durairaj VD; Simoes EA
    Arch Ophthalmol; 2007 Jun; 125(6):848-9. PubMed ID: 17563004
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
    Hirabayashi KE; Kalin-Hajdu E; Brodie FL; Kersten RC; Russell MS; Vagefi MR
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):e94-e97. PubMed ID: 27768642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhino-orbito-cerebral mucormycosis in the diabetic: a better known pathology in Tunisia].
    Anane S; Kaouech E; Belhadj S; Ammari L; Abdelmalek R; Ben Chaabane T; Ben Lakhal S; Cherif A; Ammamou M; Ben Fadhel K; Kallel K; Chaker E
    Ann Biol Clin (Paris); 2009; 67(3):325-32. PubMed ID: 19411235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of limited rhino-orbital mucormycosis without exenteration.
    Kohn R; Hepler R
    Ophthalmology; 1985 Oct; 92(10):1440-4. PubMed ID: 4069609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.
    Almannai M; Imran H; Estrada B; Siddiqui AH
    Pediatr Hematol Oncol; 2013 Apr; 30(3):184-6. PubMed ID: 23444832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Nose: Disseminated Mucormycosis.
    Danneels P; Mahieu R; Dib M; Abgueguen P; Rabier V; Klosek M; Le Govic Y; Dubée V
    Am J Med; 2018 Oct; 131(10):1182-1184. PubMed ID: 29806997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.